ITEM VIEW

Pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome in end-stage renal disease successfully treated with adalimumab

dc.contributor.authorDe Wet, J.en_ZA
dc.contributor.authorJordaan, H. F.en_ZA
dc.contributor.authorKannenberg, S. M.en_ZA
dc.contributor.authorTod, B.en_ZA
dc.contributor.authorGlanzmann, B.en_ZA
dc.contributor.authorVisser, W. I.en_ZA
dc.date.accessioned2018-08-17T06:49:51Z
dc.date.available2018-08-17T06:49:51Z
dc.date.issued2017
dc.identifier.citationDe Wet, J., et al. 2017. Pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome in end-stage renal disease successfully treated with adalimumab. Dermatology Online Journal, 23(12):1-6
dc.identifier.issn1087-2108 (online)
dc.identifier.urihttp://hdl.handle.net/10019.1/104276
dc.descriptionCITATION: De Wet, J., et al. 2017. Pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome in end-stage renal disease successfully treated with adalimumab. Dermatology Online Journal, 23(12):1-6.
dc.descriptionThe original publication is available at https://escholarship.org/uc/doj
dc.description.abstractPASH syndrome (pyoderma gangrenosum, acne, and suppurative hidradenitis) forms part of the spectrum of autoinflammatory diseases. We report an unusual case of PASH syndrome in a patient with end-stagerenal disease (ESRD) who was successfully treated with the tumor necrosis factor inhibitor, adalimumab. The case underscores the challenges associatedwith the treatment of PASH syndrome as well as the ongoing search to establish a genetic basis for the syndrome. Renal impairment has been reported in association with pyoderma gangrenosum but has notbeen described in PASH syndrome. We believe this to be the first reported case of a patient who developed PASH syndrome in the setting of ESRD.en_ZA
dc.description.urihttps://escholarship.org/uc/item/82d4m2zw#author
dc.format.extent6 pages
dc.language.isoen_ZAen_ZA
dc.publisherUniversity of California
dc.subjectChronic renal failureen_ZA
dc.subjectTumor necrosis factoren_ZA
dc.titlePyoderma gangrenosum, acne, and suppurative hidradenitis syndrome in end-stage renal disease successfully treated with adalimumaben_ZA
dc.typeArticleen_ZA
dc.description.versionPublisher's version
dc.rights.holderAuthors retain copyright


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

ITEM VIEW